SSHARE 871284: Amid rising energy prices, energy independence, and the impact of climate change, buildings are the primary consumers of energy. This underscores the importance net-zero buildings that produce as much energy as it uses over the course of a year. The EU-funded SSHARE project aims to develop innovative envelopes for buildings aimed at net zero energy, contributing significantly to European technology and creativity. Envelope is a combination of two technologies that cool or heat the building depending on the time of year using only atmospheric humidity as both thermal and electric energy supply.´ The goal of the SSHARE project is the development of the innovative Self-Sufficient Panels for the Buildings to address net zero energy buildings demands.
CATCHER 101046307: CATCHER project is aimed at development of innovative technology to exploit the atmospheric humidity for direct conversion to the electricity, thus gain a new sustainable source of renewable energy and to contribute to implementing the specific priorities for strengthening the EU leadership on renewables.
PhytoApp 101007642: The main objectives of the PhytoAPP project are design, development and delivery of the innovative water-soluble Phytochemical Inhibitors for Alzheimer and Parkinson diseases prevention. To achieve this goal the PhytoAPP project will explore the innovative nanotechnological solutions to overcome phytochemicals limitation faced by their low water-solubility via fullerene-enhanced innovative synthesis of water-soluble green Phytocomplexes, by means of cooperation between Researchers and SMEs Partners from EU and Partner’s Countries. Under PhytoAPP project it is expected to build new and enhance existing network of international and inter-sectoral cooperation in the form of joint research and innovation activities between the project Partners with multidisciplinary skills and complementary competences in nanomaterials, physics, engineering, green chemistry, biochemistry and medical science.
AquaSynapse 101086453: Core idea of this project is to establish the mechanistic basis for the positive health effects of deuterium depleted water and determine what regimens are most efficacious. Isotope content of drinking water has been shown affect the pathogenesis of cancers to ameliorate the stress response and reduce susceptibility to many diseases, but it remains unclear how the positive biological effects of heavy isotope reduction in drinking water are mediated. High concentrations of deuterium induce mitochondrial dysfunction, and very high concentrations can induce cell death, but the administration of deuterium at 91 ppm has antidepressant effects that were comparable to that of citalopram in a mouse model of depression. Use of deuterium depleted water appears to represent a safe intervention with few, if any, reported side effects, but it remains unclear at what concentrations the positive metabolic and behavioural effects become apparent. Companies in Europe now sell DDW at different concentrations to the public amidst a plethora of health claims that mostly lack in any sound scientific basis or safety data. Thus, there is an urgent need to better understand the impact of DDW on brain and behaviour at a molecular level.
EWALD 101086250: Land degradation (LD) is the world’s greatest environmental challenge affecting the environment, agriculture, and human wellbeing. Intensified by natural disasters and desertification, the LD may present potential risks and socioeconomic tension at the European Union (EU) frontier. The project aims to develop an innovative framework to provide an Early Warning System (EWS) and responses to the LD threatening the EU from its external border, using multi-source and multi-scale Earth Observation (EO) data.
INNMEDSCAN 101086178: The development of modern methods of medical diagnostics is an integral part of the work and research of scientists. And it is constantly being improved, as high-precision early diagnosis increases the chances of recovery for people suffering from dangerous diseases. One of the key developments in this area is a new hybrid PET / MRI machine that provides simultaneous Magnetic Resonance Imaging and Positron Emission Tomography. In this sense, The INNMEDSCAN main objective is to develop a highly requested equipment in medical markets, a Hybrid Magnetic Resonance Imaging / Positron Emission Tomography (PET-MRI) Scanner. For this, the partners aim to design and produce a novel highly sensitive semiconductor-based photodetector, followed by the elaboration of the working prototype detector´s module suitable for elaboration of next generation of the hybrid PET-MRI scanners.
DETMED 101129879: The DETMED project aims to contribute to the development of advanced medical gamma probed for radio-guided surgeries, that are highly requested in the medic equipment market.